Cosmetica Laser & Skin: Laser Hair Removal, Botox, Lip Fillers, Semaglutide, Microneedling, HydraFacial, BioRepeel
Cosmetica Laser & Skin: Laser Hair Removal, Botox, Lip Fillers, Semaglutide, Microneedling, HydraFacial, BioRepeel · 1133 Gray Avenue · Yuba City, CA 95991
5.0· 228 Google reviews
Listing updated October 2, 2026
No current plans confirmed — RetaMaps has not yet confirmed this practice's intentions regarding retatrutide. Inclusion on RetaMaps does not mean the provider offers or will offer retatrutide.
Care described on the practice's website
- GLP-1 medications named on site
- Medically supervised weight loss
About this practice
Cosmetica Laser & Skin is a medical spa in Yuba City, California. Its website lists laser hair removal, neuromodulators such as Botox and Dysport, fillers, microneedling, a CO2 laser peel, Hydrafacial and semaglutide for weight loss. Because it is a med spa rather than a dedicated weight-loss clinic, anyone considering semaglutide here should ask who prescribes it and how visits are supervised. On Google it holds a 5.0-star rating across 228 reviews since 2024, with 98 posted in the past year, and reviewers most often mention the staff, followed by the providers' knowledge and results.
Services & access
| Advertises semaglutide today | Yes |
| Advertises tirzepatide today | Not listed |
| Telehealth visits | Not listed |
| Cash pay accepted | — |
| Accepts insurance — per practice website | Yes |
| Accepting new patients — per practice website | Yes |
"Not listed" means we didn't find this stated on the practice's public pages — it doesn't mean no. — means unknown. Medication rows describe currently FDA-approved GLP-1 medications the practice advertises today, not retatrutide. Confirm details directly with the practice.
Review activity
Counts computed by RetaMaps from public Google reviews; most recent review 2026-09-29. Read the reviews themselves on the practice's Google listing.
What patients say
Rated ★5.0 across 228 Google reviews. Of the 100 reviews we analyzed, 100 (100%) are positive (4–5★) and 0 (0%) are negative (1–2★).
What patients like
- Friendly, helpful staff41 reviews
- Knowledgeable, professional providers21 reviews
- Weight-loss results19 reviews
- Clean, comfortable office10 reviews
Common complaints
No negative reviews among those we analyzed.
Most recent Google reviews
steven S.★★★★★2026-09-29Amazing Place and welcoming atmosphere Liz and her team are very professional and make every appointment feel great
S. D.★★★★★2026-09-29love it here. Got microneedling done and the whole experience was seamless and results are great!
Chantal C.★★★★★2026-09-19Great bilingual staff!
Carmen C.★★★★★2026-09-19Quick & great staff¡
brisa g.★★★★★2026-09-01Amazing work im obsessed 😍
Analysis by RetaMaps of reviews on this practice's public Google Business listing; review themes are detected automatically and reviews reflect their authors' opinions. See all reviews on Google.
Nearby providers in Yuba City
Forever Young Aesthetics by Robin
2192 Live Oak Boulevard · Yuba City, CA 95991
5.0(16 Google reviews · 6 in past year)
Retatrutide is Eli Lilly's investigational once-weekly triple agonist (GIP, GLP-1 and glucagon receptors). Five Phase 3 trials have reported positive results, and Lilly plans to submit it to the FDA in Q1 2027. It is not FDA-approved, has no brand name or price, and cannot be prescribed outside clinical trials or Lilly's physician-requested expanded access program. Products sold online as "research" or compounded retatrutide are not legitimate retatrutide.
- Development
- Phase 3 complete
- FDA status
- Submission planned — Q1 2027 (Lilly guidance)
- Availability
- Not commercially available
- Access routes
- Clinical trials, or Lilly's expanded access program (physician must apply)
Next milestone: TRIUMPH-5 head-to-head vs tirzepatide results (Expected ~Dec 2026)
Sources: Lilly — What to know about retatrutide · Lilly — TRIUMPH-2/TRIUMPH-3 results · BioPharma Dive — FDA submission plans · STAT — Lilly expanded access (Aug 3, 2026) · FDA — Concerns with unapproved GLP-1 drugs